Literature DB >> 27470359

[6]-Shogaol, a dietary phenolic compound, induces oxidative stress mediated mitochondrial dependant apoptosis through activation of proapoptotic factors in Hep-2 cells.

Govindhan Annamalai1, Suresh Kathiresan2, Nagappan Kannappan3.   

Abstract

Ginger (Zingiber officinale) is a well-known herb used in ethnomedicine. [6]-shogaol, a phenolic nature is a major constituent of ginger. In this study, we investigated the anticancer activity of [6]-shogaol in Laryngeal cancer (Hep-2) cells. We demonstrated the effects of [6]-shogaol on the cell growth and apoptosis in Hep-2 cells were analyzed by the generation of reactive oxygen species (ROS), the level of mitochondrial membrane potential (ΔYm), DNA damage and apoptotic morphological changes were analyzed by AO/EtBr, AO and Hoechst staining. Further, apoptotic protein expressions were analyzed by western blot analysis. Our results indicated that [6]-shogaol induces apoptosis as evidenced by loss of cell viability, enhanced ROS, lipid peroxidation results in altered mitochondrial membrane potential, increased DNA damage in Hep-2 cells. Further, the prooxidant role of [6]-shogaol inhibit Bcl-2 expression with the simultaneous up-regulation of Bax, Cytochrome c, Caspase-9 and -3 protein expressions were observed in Hep-2 cells. Thus, [6]-shogaol induces apoptosis in Hep-2 cells through inducing oxidative damage and modulate apoptotic marker expressions. Therefore, [6]-shogaol might be used as a therapeutic agent for the treatment of laryngeal cancer.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cytotoxicity; Lipid-peroxidation; Oxidative stress; Prooxidants; [6]-shogaol

Mesh:

Substances:

Year:  2016        PMID: 27470359     DOI: 10.1016/j.biopha.2016.04.044

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  7 in total

1.  In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis.

Authors:  Imran Khan; Ashutosh Bahuguna; Pradeep Kumar; Vivek K Bajpai; Sun Chul Kang
Journal:  Sci Rep       Date:  2018-01-09       Impact factor: 4.379

2.  Organelle-Targeted BODIPY Photocages: Visible-Light-Mediated Subcellular Photorelease.

Authors:  Dnyaneshwar Kand; Lorena Pizarro; Inbar Angel; Adi Avni; Dinorah Friedmann-Morvinski; Roy Weinstain
Journal:  Angew Chem Int Ed Engl       Date:  2019-02-28       Impact factor: 15.336

3.  Punicalagin promotes the apoptosis in human cervical cancer (ME-180) cells through mitochondrial pathway and by inhibiting the NF-kB signaling pathway.

Authors:  Li Zhang; Arunachalam Chinnathambi; Sulaiman Ali Alharbi; Vishnu Priya Veeraraghavan; Surapaneni Krishna Mohan; Guoliang Zhang
Journal:  Saudi J Biol Sci       Date:  2020-03-04       Impact factor: 4.219

4.  Decursinol Angelate Arrest Melanoma Cell Proliferation by Initiating Cell Death and Tumor Shrinkage via Induction of Apoptosis.

Authors:  Sukkum Ngullie Chang; Imran Khan; Chang Geon Kim; Seon Min Park; Dong Kyu Choi; Heejin Lee; Buyng Su Hwang; Sun Chul Kang; Jae Gyu Park
Journal:  Int J Mol Sci       Date:  2021-04-15       Impact factor: 5.923

5.  6-(Methylsulfonyl) hexyl isothiocyanate as potential chemopreventive agent: molecular and cellular profile in leukaemia cell lines.

Authors:  Monia Lenzi; Veronica Cocchi; Marco Malaguti; Maria Cristina Barbalace; Silvia Marchionni; Silvana Hrelia; Patrizia Hrelia
Journal:  Oncotarget       Date:  2017-12-04

6.  6-Shogaol enhances the anticancer effect of 5-fluorouracil, oxaliplatin, and irinotecan via increase of apoptosis and autophagy in colon cancer cells in hypoxic/aglycemic conditions.

Authors:  Marta Woźniak; Sebastian Makuch; Kinga Winograd; Jerzy Wiśniewski; Piotr Ziółkowski; Siddarth Agrawal
Journal:  BMC Complement Med Ther       Date:  2020-05-11

7.  Effect of 6-Shogaol on the Glucose Uptake and Survival of HT1080 Fibrosarcoma Cells.

Authors:  Angie C Romero-Arias; Luis G Sequeda-Castañeda; Andres F Aristizábal-Pachón; Ludis Morales
Journal:  Pharmaceuticals (Basel)       Date:  2019-09-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.